PAPL vs UTHR · rev $3.0M vs P/E 20, rev $1.56B
Pineapple Financial Inc. (PAPL) versus United Therapeutics Corporation (UTHR) — a side-by-side from cached financials, not a winner call.
Pineapple Financial Inc. (PAPL) is a mortgage finance company listed on AMEX.
United Therapeutics Corporation (UTHR) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported PAPL revenue for 2025-08-31 was $3.0M. Net income was -$3.6M. Revenue was up 11.1% from 2024-08-31 to 2025-08-31. PAPL currently screens at market cap $27.9M.
Latest reported UTHR revenue for 2026-06-30 was $1.56B. Net income was $607.9M. UTHR currently screens at market cap $23.41B and trailing P/E 20.4.
PAPL currently screens at market cap $27.9M. UTHR currently screens at market cap $23.41B and trailing P/E 20.4.
Not investment advice. Open the PAPL and UTHR stock pages for the full models.
Not investment advice.